The FDA will require clinical trials for updated Covid vaccines to target the LP.8.1 strain. This change may limit access to the shots, with exemptions for high-risk groups. Questions remain about the trial requirements and potential strain selection. The new policy aims to adapt to the evolving virus.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing